A randomized controlled trial on the oncologic outcomes of use of the intrauterine manipulator in the treatment of apparent uterine-confined endometrial carcinoma: the MANEC TrialStefano Uccella, Andrea Puppo, Fabio Ghezzi, Pier Carlo Zorzato, Marcello Ceccaroni, Vincenzo Dario Mandato, Roberto Berretta, Marco Camanni, Renato Seracchioli, Anna Myriam Perrone, Vito Chiantera, Giuseppe Vizzielli, Giulio Sozzi, Paolo Beretta, Martin SteinkassererSee the full list of authors
11 September 2024
Biomarker-driven targeted therapy in patients with recurrent platinum-resistant epithelial ovarian cancer (BRIGHT): protocol for an open-label, multicenter, umbrella studyYu Xu, Fan Xiong, Huayi Li, Hong Zheng, Jie Jiang, Qingshui Li, Guiling Li, Weidong Zhao, Rong Li, Jundong Li, Rong Xie, Ruifang An, Huifeng Zhang, Qinglei Gao
23 April 2024
A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11)Hyun-Woong Cho, Hee-Seung Kim, Jeong-Yeol Park, Yoo Young Lee, Myong Cheol Lim, Sung-Jong Lee, Kyung-Jin Min, Kyung Jin Eoh, Kwang Beom Lee, Min Kyu Kim, Jae Yun Song, Seung-Hyuk Shim, Yong Il Ji, Yong-Joong Song, Suk-Joon ChangSee the full list of authors
20 August 2024
ENGOT-EN20/GOG-3083/XPORT-EC-042 – A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial designIgnace Vergote, Alejandro Perez Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon van Gorp, Debra Richardson, Michael McCarthySee the full list of authors
16 April 2024
ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancerMario M Leitao,, Jr, Alexia Iasonos, Morgan Tomberlin, Lea A Moukarzel, Hannah Price, Gabrielle Bennetti, Bhavani Ramesh, Dennis S Chi, Kara Long Roche, Yukio Sonoda, Ahmed Al-Niami, Jennifer J Mueller, Ginger J Gardner, Vance BroachSee the full list of authors
21 March 2024
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma—a multicenter, single-arm, phase II, clinical proof-of-concept studyM I E van Poelgeest, Kim E Kortekaas, Helena C van Doorn, Maaike Oonk, Hans W Nijman, Ingrid Boere, Anneke L Eerkens, Anna K L Reyners, Patricia C Ewing-Graham, Joost Bart, Tjalling Bosse, Marij J P Welters, Judith R Kroep, Sjoerd H van der Burg
23 June 2024
An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial)Luis Chiva, Pilar Ordás, Nerea Martin-Calvo, Jose Manuel Aramendia, Luisa Sanchez Lorenzo, Alejandro Gallego Martínez, Ángel Vizcay, Jose Angel Minguez, Nabil Manzour, Daniel Vázquez-Vicente, Enrique Chacon, Teresa Castellanos, Antonio Gonzalez Martin
13 March 2024
Robotic-assisted versus conventional laparoscopic surgery in the management of obese patients with early endometrial cancer in the sentinel lymph node era: a randomized controlled study (RObese)Giorgia Dinoi, Vincenzo Tarantino, Nicolò Bizzarri, Emanuele Perrone, Ilaria Capasso, Diana Giannarelli, Denis Querleu, Maria Consiglia Giuliano, Anna Fagotti, Giovanni Scambia, Francesco Fanfani
7 February 2024
Primary chemoradiation versus neoadjuvant chemotherapy followed by surgery as treatment strategy for locally advanced vulvar carcinoma (VULCANize2)Frédéric Amant, Anne Fleur van Velzen, An Reyners, Henry Zijlmans, Eva E Schaake, Linda Nooij
6 May 2024
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trialTine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys, Frédéric Selle, Inge Baas, Anne-Sophie Van Rompuy, Diether Lambrechts, Els Van Nieuwenhuysen
6 March 2024
